Michael D Stensland

Summary

Publications

  1. doi request reprint An examination of costs, charges, and payments for inpatient psychiatric treatment in community hospitals
    Michael Stensland
    Agile Outcomes Research, Inc, 3560 Nebula Lane, Rochester, MN 55902, USA
    Psychiatr Serv 63:666-71. 2012
  2. pmc Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study
    Virginia S Haynes
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    BMC Psychiatry 12:222. 2012
  3. doi request reprint Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 12:708-15. 2009

Collaborators

  • Virginia S Haynes
  • Andrew P Yu
  • Lei Xu
  • Virginia L Stauffer
  • Bruce J Kinon
  • Baojin Zhu
  • Haya Ascher-Svanum
  • Glenn Philips
  • Pavel Atanasov
  • Howard Birnbaum
  • Rym Ben-Hamadi

Detail Information

Publications3

  1. doi request reprint An examination of costs, charges, and payments for inpatient psychiatric treatment in community hospitals
    Michael Stensland
    Agile Outcomes Research, Inc, 3560 Nebula Lane, Rochester, MN 55902, USA
    Psychiatr Serv 63:666-71. 2012
    ..Despite its resource intensity, the costs of inpatient psychiatric hospitalizations in the United States are not well understood. The objective of this research was to provide cost estimates for inpatient psychiatric care...
  2. pmc Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study
    Virginia S Haynes
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    BMC Psychiatry 12:222. 2012
    ..This post-hoc analysis of a 3-year study compared the costs of mental health services and functional outcomes between individuals with schizophrenia who met or did not meet cross-sectional symptom remission at study enrollment...
  3. doi request reprint Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population
    Andrew P Yu
    Analysis Group, Inc, Boston, MA, USA
    Value Health 12:708-15. 2009
    ..Compare annual health-care costs and resource utilization associated with olanzapine versus quetiapine for treating schizophrenia in a Medicaid population...